Two Studies Show Medical Cannabis Laws Associated with Significant Reductions in Opioid Prescribing in Medicare Part D Population.

Prescriptions for all opioids decreased by 3.742 million daily doses per year when medical cannabis dispensaries opened.  Medical cannabis policies may be one mechanism that can encourage lower prescription opioid use and serve as a harm abatement tool in the Continue reading Two Studies Show Medical Cannabis Laws Associated with Significant Reductions in Opioid Prescribing in Medicare Part D Population.

World Health Organization – Update of Cannabis and its medical use

The World Health Organization issues report on Cannabis and its medical use.   Summary and Conclusions “It has been advanced that whole plant cannabis can be used for multiple therapeutic purposes. The evidence presented on potential medical uses and risks Continue reading World Health Organization – Update of Cannabis and its medical use

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Orrin Devinsky, M.D., J. Helen Cross, Ph.D., F.R.C.P.C.H., Linda Laux, M.D., Eric Marsh, M.D., Ian Miller, M.D., Rima Nabbout, M.D., Ingrid E. Scheffer, M.B., B.S., Ph.D., Elizabeth A. Thiele, M.D., Ph.D., and Stephen Wright, M.D., for the Cannabidiol in Dravet Continue reading Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Cannabis as Stigmatized Medicine

In a article published in the February 2013, Harm Reduction Journal  entitled, “Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study” authors Joan L Bottorff, Laura JL Bissell, Lynda G Balneaves, John L Oliffe, N Rielle Capler and Jane Buxton, state, “Experiences of stigma among those with illness and the Continue reading Cannabis as Stigmatized Medicine